Predictions
Inventiva SA
Start price
Target price
Perf. (%)
€11.54
10.09.21
10.09.21
€8.00
10.09.22
10.09.22
-63.65%
11.09.22
11.09.22
Could be worthwhile Investment >10% per year
Inventiva SA
Start price
Target price
Perf. (%)
€2.08
10.09.21
10.09.21
€12.00
-
10.09.21
10.09.21
Could be worthwhile Investment >10% per year
Inventiva SA
Start price
Target price
Perf. (%)
€2.08
10.09.21
10.09.21
€8.00
-
10.09.21
10.09.21
Could be worthwhile Investment >10% per year
Poxel S.A.
Start price
Target price
Perf. (%)
€6.46
06.09.21
06.09.21
€5.00
06.09.22
06.09.22
-9.30%
07.10.21
07.10.21
Could be worthwhile Investment >10% per year
Valneva SE
Start price
Target price
Perf. (%)
€20.78
06.09.21
06.09.21
-
06.09.22
06.09.22
-39.56%
13.09.21
13.09.21
Risky Investment
Innate Pharma
Start price
Target price
Perf. (%)
€4.80
05.09.21
05.09.21
-
05.09.22
05.09.22
-47.79%
07.03.22
07.03.22
Probably not worthwhile Investment
Innate Pharma
Start price
Target price
Perf. (%)
€4.80
04.09.21
04.09.21
€2.00
04.09.22
04.09.22
37.71%
18.09.21
18.09.21
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Innate Pharma
Start price
Target price
Perf. (%)
€6.20
03.09.21
03.09.21
-
03.09.22
03.09.22
-25.29%
06.09.21
06.09.21
Risky Investment
Valneva SE
Start price
Target price
Perf. (%)
€20.18
03.09.21
03.09.21
€30.00
03.09.22
03.09.22
-59.38%
03.09.22
03.09.22
Could be worthwhile Investment >10% per year
Future proof or reliable business model
Some uniques
Higher risks for its business
Valneva SE
Start price
Target price
Perf. (%)
€13.84
25.08.21
25.08.21
-
25.08.22
25.08.22
-32.23%
26.08.22
26.08.22
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Erytech Pharma S.A.
Start price
Target price
Perf. (%)
€5.10
30.07.21
30.07.21
-
30.07.22
30.07.22
2.55%
08.08.21
08.08.21
Risky Investment
Valneva SE
Start price
Target price
Perf. (%)
€11.24
20.07.21
20.07.21
€20.00
20.07.22
20.07.22
116.90%
25.11.21
25.11.21
Could be worthwhile Investment >10% per year
Very valuable balance sheet
Abivax S.A.
Start price
Target price
Perf. (%)
€30.50
28.06.21
28.06.21
€25.00
28.06.22
28.06.22
-16.39%
01.12.21
01.12.21
Future proof or reliable business model
Probably not worthwhile Investment
overvalued
Very low/no dividend yield expected
Valneva SE
Start price
Target price
Perf. (%)
€10.89
17.06.21
17.06.21
€8.00
17.06.22
17.06.22
3.21%
20.07.21
20.07.21
Could be worthwhile Investment >10% per year
Very valuable balance sheet
Virbac S.A.
Start price
Target price
Perf. (%)
€275.00
28.04.21
28.04.21
€270.00
28.04.22
28.04.22
43.82%
25.10.21
25.10.21
Could be worthwhile Investment >10% per year